SCHEMBL31670511

SCHEMBL31670511

OCC12CC(Nc3nc(Cl)nc4c3SCC4)(C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL373964 0.81 — —
SCHEMBL30639334 0.79 LATS1 (0.33) —
SCHEMBL14734141 0.79 LATS1 (0.33) —
SCHEMBL23068559 0.78 — —
SCHEMBL31630700 0.77 — —
SCHEMBL31622422 0.74 — —
SCHEMBL29277041 0.73 PDE4B (0.34) —
SCHEMBL30678844 0.73 PDE4B (0.34) —
SCHEMBL31474607 0.72 — —
SCHEMBL187242 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008788-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE SUZHOU ARK BIOPHARMACEUTICAL CO LTD (CN) 2026-01-08 — — US disclosed
EP-4596554-A1 AZA-FUSED RING COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE Suzhou Arkbiopharmaceutical Co., Ltd. (CN) 2025-08-06 — — EP disclosed
Send feedback